Search Results - "Myakova, N V"

Prognostic value of baseline and interim [18F]FDG PET metabolic parameters in pediatric Hodgkin’s lymphoma by Yadgarov, Mikhail Ya, Dunaykin, M. M., Shestopalov, G. I., Kailash, C., Kireeva, E. D., Myakova, N. V., Likar, Yu. N.

“…Background Hodgkin lymphoma (HL) in pediatric populations has a high survival rate but poses risks for long-term morbidities. Although [ 18…”
Get full text

Use of crizotinib for refractory ALK-positive lymphomas by Shelikhova, L N, Fominykh, V V, Abramov, D S, Myakova, N V, Maschan, M A, Maschan, A A

“…To evaluate the safety and efficacy of crizotinib used in pediatric patients with relapsed or refractory ALK-positive anaplastic large-cell lymphoma (ALCL)…”
Get full text

Hodgkin's lymphoma by Demina, E. A., Tumyan, G. S., Moiseeva, T. N., Mikhailova, N. B., Myakova, N. V., Rumyantsev, A. G., Maschan, A. A., Kaplanov, K. D., Shmakov, R. G., Falaleeva, N. A., Ptushkin, V. V., Osmanov, E. A., Poddubnaya, I. V., Baikov, V. V., Kovrigina, A. M., Konovalov, D. M., Trofimova, O. P., Sotnikov, V. M., Ilin, N. V., Vinogradova, Yu. N., Nechesnyuk, A. V., Parkhomenko, R. A., Stefanov, D. N., Nevolsky, A. A., Ivanov, S. A., Khaylova, Zh. V.

“…Clinical recommendations…”
Get full text

Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review) by Komratova, K. A., Abugova, Yu. G., Ozerov, S. S., Abramov, D. S., Tereshchenko, G. V., Myakova, N. V.

“…The central nervous system (CNS) involvement in patients with non-Hodgkin’s lymphomas is not uncommon, especially in children with mature B-cells lymphomas,…”
Get full text

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA by Chernyshova, E. V., Abramov, D. S., Konovalov, D. M., Larin, S. S., Myakova, N. V.

“…ALK-positive anaplastic large cell lymphoma is a heterogeneous group of mature T-cell non-Hodgkin lymphoma, and is characterized by CD30/Ki-1 expression…”
Get full text

Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities by Demina, I. A., Verzhbitskaya, T. Yu, Kashpor, S. A., Plyasunova, S. A., Dubrovina, M. E., Fechina, L. G., Myakova, N. V., Samochatova, E. V., Maschan, A. A., Popov, A. M.

“…Bone marrow tumor blasts immunophenotyping is an essential part of Burkitt lymphoma/leukemia (BL) and B-cell precursor acute lymphoblastic leukemia (BCP-ALL)…”
Get full text

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE by Skvortsova, Yu. V., Shelichova, L. N., Myakova, N. V., Biyachuev, E. R., Konovalov, D. M., Abramov, D. S., Maschan, M. A., Skorobogatova, E. V., Rumyantsev, A. G., Maschan, A. А.

“…Secondary malignant diseases are dangerous long-term complications of allogeneic hematopoietic stem cell transplantation (HSCT). This article describes the…”
Get full text

Brentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience by Myakova, N. V., Evstratov, D. A., Abramov, D. S., Konovalov, D. M., Pshonkin, A. V., Litvinov, D. V.

“…Despite significant advances in the treatment of lymphomas in children remain a small proportion of patients with refractory or recurrent disease. An effective…”
Get full text

Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports by Zerkalenkova, E. A., Illarionova, O. I., Kazakova, A. N., Ponomareva, N. I., Baydun, L. V., Osipova, E. Yu, Dubrovina, M. E., Popov, A. M., Konyukhova, T. V., Plyasunova, S. A., Myakova, N. V., Maschan, A. A., Olshanskaya, Yu. V.

“…Lineage switch is a rare phenomenon in which a transition from lymphoid to myeloid was observed in relapse of acute leukemia, or vice versa. This paper…”
Get full text

Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization by Smirnova, N. V., Myakova, N. V., Belogurova, M. B., Ryskal, O. V., Nikonova, O. E., Sharapova, G. R., Fedorova, A. S., Grigorieva, N. A., Shamardina, A. V., Ponomareva, N. I., Abramov, D. S., Konovalov, D. M., Dubrovina, M. E., Maschan, A. A., Samochatova, E. V.

“…The results of two consecutive multicenter clinical trials enrolled 241 patient with childhood mature B-cells non-Hodgkin lymphomas/leukemia are presented…”
Get full text

Steroid glaucoma in patients with hemoblastosis by Smirnova, A B, Pershin, B S, Myakova, N V

“…Modern methods of treatment have significantly increased the survival rate of children with oncohematological diseases, and along with it the importance of…”
Get more information

ALK-positive anaplastic large cell lymphoma of paranasal sinuses: two cases report and literature review by Abramov, D S, Fedorova, A S, Tuzova, E A, Myakova, N V, Konovalov, D M

“…ALK-positive anaplastic large cell lymphoma is a rare T-cell lymphoma with ALK gene rearrangement that develops in children and young adults. The disease…”
Get more information

Acute lymphoblastic leukemia in children by M. A. Maschan, N. V. Myakova

Get full text

Cardiac toxicity in children and adolescents with Hodgkin lymphoma after chemoradiotherapy by R. I. Feoktistov, O. A. Schurova, J. G. Abugova, J. Yu. Dyakonova, O. V. Makarova, N. V. Myakova, N. B. Senyakovich, E. V. Samochatova

“…During the last decade in Russian clinics significant success in treatment of children with Hodgkin lymphoma has been reached. However, the using of…”
Get full text

Treatment results of Hodgkin’s lymphoma in children and adolescents: data of a monocenter study by R. I. Feoktistov, J. V. Rumyantseva, Yu. G. Abugova, Yu. Yu. Dyakonova, O. V. Makarova, N. V. Myakova, E. V. Samochatova

“…Treatment results of children and adolescents with Hodgkin’s lymphoma (HL) treated at the Russian Children Clinical Hospital (Moscow) was described. 47…”
Get full text

Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma by S. S. Kulikova, S. V. Semochkin, D. V. Litvinov, E. V. Inuschkina, N. V. Myakova, K. L. Kondratchik, L. V. Baidun, D. M. Konovalov, D. A. Peregudov, L. N. Schelichova, E. V. Samochatova

“…Lymphoblastic lymphoma (LBL) is one of predominant childhood non-Hodgkin’s lymphoma (NHL) subtypes and consists 25—30 %.   The study purpose was to investigate…”
Get full text

Endothelial injury syndromes after hematopoietic stem cell transplantation: analyzing clinical case by Y. V. Skvortsova, D. N. Balashov, Y. Y. Djakonova, Z. M. Dishlevaya, E. E. Kurnikova, N. V. Myakova, V. P. Nazhimov, E. V. Skorobogatova, L. N. Shelikhova, I. P. Shipitsina, P. E. Trakhtman, A. A. Maschan

“…Early complications of hematopoietic stem cell transplantation (HSCT) of vascular origin within the first 30-60 days after HSCT, which are resulting from…”
Get full text

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications by E. V. Samochatova, L. N. Schelikhova, M. B. Belogurova, A. V. Schamardina, E. V. Bascharova, D. V. Litvinov, N. V. Myakova, L. G. Fechina, O. P. Chlebnikova, E. V. Inuschkina, O. V. Riskal, P. Z. Schammasov, I. M. Yunusova, S. Yu. Umnova, D. M. Konovalov, A. G. Talalaev, J. V. Roumiantseva, A. A. Maschan

“…Therapy results of 61 patients (children and adolescents, 2—17 years of age; a median — 8.76 years) with B-cells non-Hodgkin lymphomas III—IV stage and B-cell…”
Get full text

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia by N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan

“…Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are…”
Get full text

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol by M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky

“…The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG)…”
Get full text